Payment & Shipping Terms:
|Packaging Details:||Safe And Discreet Packaging||Chemicals Name:||BK-MMDA|
|Colour:||Pink/ White/ Brown/ Gold/ Red/ Yellow Etc||Chemical Name:||Methylone/ M1/ Molly|
Pink/ white / brown crystals 99% purity BKMDA BKMMA BKEBDP CAS186028-79-5
Medicine Most Popular Reliable Research Chemicals BK EBDP Crystal 186028-79-5
See also: Research
As of 2016, has no accepted medical indications. Before it was widely banned, it saw limited use in therapy.
A small number of therapists continue to use in therapy despite its illegal status.
5F-AB-PINACA is anthat is derived from a series of compounds originally developed by in 2009 as medication, and has been sold online
5F-AB-PINACA has been reported to be a potent of the andwith values of 0.48 nM and 2.6 nM respectively.Its metabolism has been described in literature.
U-50488 is a drug which acts as a highly selective , but without any effects. It has candeffects,and reverses the memory impairment produced by drugs. U-50488 was one of the first selective kappa agonists invented and research on its derivatives has led to the development of a large family of related compounds
3-Methoxyeticyclidine (3-MeO-PCE) is that is qualitatively similar to PCE AND PCP and has been sold online as
4-Methoxyphencyclidine (methoxydine, 4-MeO-PCP) is a drug that has been sold online as a The synthesis of 4-MeO-PCP was first reported in 1965 by the medicinal chemist Victor Maddox.A 1999 review published by a chemist using the pseudonym John Q. Beagle suggested the potency of 4-MeO-PCP in man was reduced relative to PCP, two years later Beagle published a detailed description of the synthesis and qualitative effects of 4-MeO-PCP,
Methaqualone, sold under the brand name Quaaludein the US and Mandrax in the UK and South Africa, is medication. It is a member of the e class.
The sedative–hypnotic activity of methaqualone was first noted by researchers in the 1950s. In 1962, methaqualone was patented in the US by Wallace and Tiernan. Its use peaked in the early 1970s as a or the treatment
Etaqualone (Aolan, Athinazone, Ethinazone is a class and is an analogue of that was developed in the 1960s and marketed mainly in France and some other European countries. It has and properties resulting from its agonist activity at the β-subtype of the, and was used for the treatment of
Flunitrazepam, also known as Rohypnol among others,is an intermediate acting used in some countries to treat severe insomnia and in fever, early in anesthesia.Just as with other hypnotics, flunitrazepam should be strictly used only on a short-term basis or by those with chronic insomnia on an occasional basis. Flunitrazepam has been referred to as a even though its incidence is very rare in cases that have been reported.
Isopropylphenidate (also known as IPH and IPPD) is a based drug, closely related to but with the methyl replaced by an ester. It has similar effects to methylphenidate but with a longer duration of action,[ and was banned in the UK as a T from April 2015 following its unapproved sale as a
It is illegal in Lithuania to use, buy, possess, transport, sell or import Isopropylphenidate
25I-NBOMe (2C-I-NBOMe, Cimbi-5, also shortened to "25I", and colloquially referred to as "N-bomb" is a and derivative of the psychedelicIt was discovered in 2003 by chemist Ralf Heim at the who published his findings in his PhD dissertation. The compound was subsequently investigated by a team at led by
Nimetazepam (marketed under brand name Erimin and Lavol) is an intermediate-acting drug which is a derivative. It was first synthesized by a team at Hoffmann-La Roche in 1962. It possesses and properties. Nimetazepam is also an It is sold in 5 mg tablets known as Erimin and Lavol. It is generally prescribed for the short-term treatment of in patients who have difficulty falling asleep or maintaining sleep. The sole global manufacturer of Nimetazepam (Sumitomo Japan) has ceased manufacturing Erimin since early November 2015. Patients being prescribed Erimin are being switched to other hypnotics, e.g. etc.
2C-B or 2,5-dimethoxy-4-bromo is a of the. It was first synthesized by in 1974. In Shulgin's book , the dosage range is listed as 12–24 mg. 2C-B is sold as a white powder sometimes pressed in tablets or gel caps and is also referred to by a number of other names.The drug is usually taken orally, but can also be or vaporized.
6-MAPB (1-(benzofuran-6-yl)-N-methylpropan-2-amine) is a psychedelic and entactogenic drug which is structurally related to 6-APB and . It is not known
Oxycodone has been in clinical use since 1916, and it is used for managing moderate to moderately severe acute or chronic It has been found to improve for those with many types of pain.[ Experts are divided regarding use for non cancer-related chronic pain, as most opioids have great potential for dependence and may also create
Diclazepam (Ro5-3448), also known as chlorodiazepam and 2'-chloro-diazepam, is a . It was first synthesized by and his team at Hoffman-La Roche in 1960.It is not currently approved for use as a medication, but rather sold as a Efficacy and safety have not been tested in humans.
related to It possesses structural similarity to several and has as a
is often considered the drug of choice within the rave culture and is also used at clubs, festivals and house parties. In the rave environment, the sensory effects from the music and lighting are often highly synergistic with the drug. The psychedelic amphetamine quality of offers multiple reasons for its appeal to users in the rave setting. Some users enjoy the feeling of mass communion from the inhibition-reducing effects of the drug, while others use it as party fuel because of the drug's stimulatory effects. is used less frequently than other stimulants, typically less than once per week.
is sometimes taken in conjunction with other psychoactive drugs, such as LSD, psilocybin mushrooms, and ketamine. Users sometimes use mentholated products while taking for its cooling sensation.